AKYLA
/ Financials
Markets
Screener
Financials
Research
Chat
Equity / BIOLOGICAL PRODUCTS, (NO DIAGNOSTIC SUBSTANCES)
ELOXX PHARMACEUTICALS INC
OTC Link · usd
SIC 2836 · BIOLOGICAL PRODUCTS, (NO DIAGNOSTIC SUBSTANCES)
FIGI BBG001S799Q4
12.80
▼ 0.32 (-2.44%)
As of 2026-10-23
Price / Volume
1M
6M
1Y
Valuation
Market Cap
$51.7M
Enterprise Value
—
Trailing P/E
—
Price / Sales
—
EV / Revenue
—
EV / EBITDA
—
Financial Highlights
Revenue (TTM)
—
Net Income (TTM)
—
EBITDA
—
Diluted EPS (TTM)
—
EBITDA Margin
—
Net Debt
—
Trading Information
Previous Close
13.12
Day's Range
12.80 – 14.00
52-Week Range
0.02 – 23.40
Volume
27.6K
Avg Volume
24.3K
Share Statistics
Shares Outstanding
4.0M
Employees
—
Exchange
OTC Link
Listed
—
Share count as of August 7, 2026
ELOXX PHARMACEUTICALS INC (ELOX) Financial Statements
View
Income Statement
Detail
Standard
Period
Quarterly
Loading Income Statement…
Key questions about ELOXX PHARMACEUTICALS INC (ELOX)
What is ELOXX PHARMACEUTICALS INC's Market Cap?
ELOXX PHARMACEUTICALS INC's Market Cap is $51.7M, based on as-reported figures from SEC (XBRL) filings.
Akyla / Financials · ELOX
As-filed SEC (XBRL) data
Showing the most recent year. Subscribe for full statement history.
Subscribe
Income Statement
(in thousands of USD, except per-share data)
Source: Akyla.ai
Line Item
Jun 30, 2026
Jun 30, 2025
Operating expenses:
Research and development
2,840.0
General and administrative
1,610.0
Total operating expenses
4,450.0
Loss from operations
(4,450.0)
Other expense, net
52.0
Net loss
(4,502.0)
Net loss per share, basic
(0.66)
Net loss per share, diluted
(0.66)